Ambey Laboratories Limited (NSE:DHANSA)
India · Delayed Price · Currency is INR 25.00
0.00 (0.00%)
At close: May 29, 2026
Ambey Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 55.23 | 47.83 | 77.22 | 52.4 | 35.75 |
Depreciation & Amortization | 21.98 | 23.61 | 22.75 | 27.19 | 26.7 |
Other Amortization | - | 1.82 | 2.4 | 2.44 | 3 |
Loss (Gain) From Sale of Assets | -0.13 | 0.07 | - | - | - |
Loss (Gain) From Sale of Investments | - | -1.11 | - | - | - |
Other Operating Activities | 759.18 | 28.65 | -18.85 | 27.03 | 50.3 |
Change in Accounts Receivable | -533.84 | -217.19 | -150.07 | 49.72 | -15.2 |
Change in Inventory | -315.42 | -93.39 | -34.54 | -63.69 | -20.19 |
Change in Accounts Payable | 62.77 | -81.73 | -14.02 | 13.53 | -13.2 |
Change in Other Net Operating Assets | -93.44 | -53.38 | -16.36 | -8.09 | -11.09 |
Operating Cash Flow | -43.68 | -344.82 | -131.46 | 100.53 | 56.07 |
Operating Cash Flow Growth | - | - | - | 79.29% | 104.40% |
Capital Expenditures | -492.78 | -135.18 | -51.1 | -30.92 | -7.59 |
Investment in Securities | 10.18 | -1.28 | -1.81 | -6.05 | - |
Other Investing Activities | 0.84 | 1.5 | 0.1 | 0.06 | 0.06 |
Investing Cash Flow | -481.76 | -134.97 | -52.82 | -36.9 | -7.53 |
Short-Term Debt Issued | 207.46 | 167.73 | 124.03 | - | 4.11 |
Long-Term Debt Issued | 189.25 | 171.31 | 133.52 | - | - |
Total Debt Issued | 396.71 | 339.04 | 257.56 | - | 4.11 |
Short-Term Debt Repaid | - | - | - | -28.25 | - |
Long-Term Debt Repaid | - | -227.05 | -102.33 | -15.72 | -24.36 |
Total Debt Repaid | - | -227.05 | -102.33 | -43.97 | -24.36 |
Net Debt Issued (Repaid) | 396.71 | 111.99 | 155.23 | -43.97 | -20.25 |
Issuance of Common Stock | - | 425.54 | 46.5 | - | - |
Other Financing Activities | 143.51 | -54.12 | -17.78 | -18.37 | -30.51 |
Financing Cash Flow | 540.22 | 483.42 | 183.95 | -62.34 | -50.76 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | 14.78 | 3.63 | -0.33 | 1.29 | -2.22 |
Free Cash Flow | -536.46 | -480.01 | -182.57 | 69.61 | 48.48 |
Free Cash Flow Growth | - | - | - | 43.58% | 215.67% |
Free Cash Flow Margin | -37.55% | -36.12% | -14.97% | 6.48% | 5.71% |
Free Cash Flow Per Share | -21.47 | -20.65 | -10.04 | 3.92 | 9.61 |
Cash Interest Paid | - | 29.12 | 17.78 | 18.37 | 30.51 |
Cash Income Tax Paid | - | 11.29 | 12.47 | -6.1 | -7.66 |
Levered Free Cash Flow | -539.04 | -530.32 | -219.56 | 30.36 | -1.48 |
Unlevered Free Cash Flow | -522.64 | -513.02 | -205.12 | 42.52 | 17.59 |
Change in Working Capital | -879.93 | -445.69 | -214.98 | -8.53 | -59.68 |